Dioxaphetyl butyrate
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| Ethyl 4-morpholin-4-yl-2,2-di(phenyl)butanoate | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? (US) |
| Routes | Oral, Other ROA Unknown |
| Identifiers | |
| CAS number | 467-86-7 |
| ATC code | None |
| PubChem | CID 48194 |
| UNII | G751H98FY4 |
| Synonyms | Amidalgon, Spasmoxal |
| Chemical data | |
| Formula | C22H27NO3 |
| Mol. mass | 353.45 g/mol |
| SMILES | eMolecules & PubChem |
| |
Dioxaphetyl butyrate (INN; trade names Amidalgon, Spasmoxal) is an opioid analgesic which is a diphenylacetic acid derivative, related to other open-chain opioid drugs such as dextropropoxyphene, levacetylmethadol (LAAM), lefetamine and dimenoxadol.
It produces similar effects to other opioids, including dependence, euphoria, analgesia, sedation, constipation, dizziness and nausea.
[edit] References
| This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (November 2009) |
| This analgesic-related article is a stub. You can help Wikipedia by expanding it. |

